DARPP-32 and t-DARPP isoform in non-small cell lung cancer (NSCLC): could they drive patients’ clinical management and be a therapeutic target?

Documenti analoghi

• The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?
  di: Lamberti, Giuseppe, et al.
  Pubblicazione: (2020)
• Clinical implications and future perspectives in testing non-small cell lung cancer (NSCLC) for anaplastic lymphoma kinase (ALK) gene rearrangements
  di: Gelsomino, Francesco, et al.
  Pubblicazione: (2015)
• ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation
  di: Alam, Sk. Kayum, et al.
  Pubblicazione: (2020)
• DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration
  di: Alam, Sk. Kayum, et al.
  Pubblicazione: (2018)
• Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer
  di: Parisi, Claudia, et al.
  Pubblicazione: (2020)